Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Maximize Value

Developing strategies to accelerate the shift from volume to value

Summary of CY2022 Advance Notice Summary Part II

CMS proposes Stars rating changes, revises MA plan definitions, calls for new COVID-19 vaccination measures, and more.

Principal, Oliver Wyman Actuarial Consulting
Principal, Oliver Wyman Actuarial Consulting
Senior Consultant, Oliver Wyman
Senior Consultant, Oliver Wyman
Senior Consultant, Oliver Wyman

The nation's new "normal" may not come until Q4 of 2021. Companies must consider what is sustainable and where to adjust for the long haul.

Partner and CMO, Health and Life Sciences, Oliver Wyman
Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman

How extended periods of suppressed utilization and a regulatory pause on record collection may influence plans' anticipated results next year.

Principal, Health and Life Sciences, Organizational Effectiveness, Oliver Wyman
Senior Advisor, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Key Takeaways from HLTH's GoLIVE Webinar

Wellframe, BlueCross BlueShield of Tennessee, Blue Cross Blue Shield of Massachusetts, and Oliver Wyman share their perspectives on digital care technology.

How Market Trends and Dynamics are Impacting Insurers' Bottom Lines

An analysis of market profitability and capitalization trends as well as new insights into insurers' recent claims experiences.

Principal, Actuarial, Oliver Wyman
Senior Consultant, Oliver Wyman
Senior Consultant, Oliver Wyman

Insights in your inbox

Subscribe

The ideal Stars leader of tomorrow needs a specific skill set to produce consistently high Stars rating results for an organization.

Principal, Health and Life Sciences, Oliver Wyman
Partner, Organizational Effectiveness, Health and Life Sciences, Oliver Wyman
Former President of Government Business, Anthem/BCBSM, Senior Adviser, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

An executive interview with Bruce Broussard on Humana's strategic pillars, partnership decisions, and ongoing resiliency.

President and CEO, Humana

How HRAs can empower employees to choose the coverage that meets their needs while empowering employers to offer competitive health choices.

Founder and CEO, Softheon
Principal, Wild Blue Health Solutions

Part 4: State-by-State Market Impact

Six factors that dictate the kind of health coverage people who've lost their jobs want next.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Oliver Wyman Actuarial Consulting
Senior Consultant, Oliver Wyman

Healthcare Cost and Utilization During COVID-19

An analysis of what claim payments and delays may look like later this year.

Practice Leader, Oliver Wyman Actuarial Consulting
Principal, Actuarial, Oliver Wyman

Insights in your inbox

Subscribe